Related Experiment Video
Updated: Aug 23, 2026

A Direct, Early Stage Guanidinylation Protocol for the Synthesis of Complex Aminoguanidine-containing Natural Products
Published on: September 9, 2016
Structure-based design of amidinophenylurea-derivatives for factor VIIa inhibition
Otmar Klingler1, Hans Matter, Manfred Schudok
1Aventis Pharma Deutschland GmbH, Building G878, D-65926 Frankfurt, Germany. otmar.klinger@aventis.com
Abstract:
The amidinophenylurea scaffold was earlier shown to provide an excellent template for the synthesis of novel and potent inhibitors of the blood coagulation factor VIIa. In this contribution we describe the structure-based design of potent ligands guided by X-ray crystallography, molecular modeling and docking studies. The design and synthetic efforts were directed towards novel modifications to explore the protease binding region close to the S4 subsite.
Related Concept Videos
Inhibitors Of Virion Release
Antiviral Nucleoside Inhibitors
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Antifungal Agents
Preparation of 1° Amines: Azide Synthesis
Azide ions act as good nucleophiles and react with unhindered alkyl halides to form alkyl azides. Alkyl azides do not participate in further nucleophilic substitution reactions, thereby eliminating the chances of polyalkylated products. Alkyl azides are reduced by hydride-based reducing agents, like lithium aluminum...
Biopharmaceutical Factors Influencing Drug Product Design: Overview
